Rapid autopsy protocol for small cell lung cancer patients
Part of Cancer, Lungs & breathing clinical trials.
This study looks at a planned, faster way to collect information from patients’ bodies after death who have small cell lung cancer. The goal is to better understand the disease and potentially improve future care, with consent from the patient or their authorized representative.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old when you agree to join
- You must agree in writing to take part and allow medical information to be shared (HIPAA authorization)
- You must currently have a diagnosis of small cell lung cancer
- There may be additional steps required after you enroll, so you’ll be contacted to confirm details
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects blood and tumor samples from people newly diagnosed with small cell lung cancer to study how genetic markers can predict treatment success and monitor disease over time.
This study collects tissue (and follows patients over time) to better understand the natural course of several types of chest cancers. It may help researchers learn which tests and treatments work best in different cancer types.
This observational study collects information and lab samples from people with extensive-stage small cell lung cancer. It may help researchers understand how patients respond and improve future care, but it usually does not add new treatment for you.
This study uses a lab test called “proteomics” to learn more about newly diagnosed small cell lung cancer (SCLC). It may help researchers understand the disease better and improve future treatment decisions, while participants also receive standard chemotherapy.
This study will follow people with advanced small cell lung cancer to learn more about how different treatments work in the real world. It may help doctors understand what helps patients live longer and feel better.
This trial is for adults with small cell lung cancer where your diagnosis is confirmed by a tissue test. The study looks at molecular (tumor-level) features to help guide treatment choices that may fit you better.
Hear when a new Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.